Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature (Q31147797)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

James M Stone

1

0 references

author name string

John M Davis

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Stefan Leucht

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Lyn S Pilowsky

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

26 February 2008

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Schizophrenia Bulletin

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

35

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

789-797

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Dose response and dose equivalence of antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Hippocampal neurons in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

MRI anatomy of schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Risperidone in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

21 June 2018

The cerebral cortex: a case for a common site of action of antipsychotics

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBN009

21 January 2018

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

31 October 2018

Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

31 October 2018

Regional selectivity in clozapine treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

31 October 2018

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

31 October 2018

Limbic selectivity of clozapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696370

31 October 2018

Double-blind study of clozapine dose response in chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basal ganglia and cerebellar loops: motor and cognitive circuits

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The limbic cortex in schizophrenia: focus on the anterior cingulate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18303092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/SCHBUL/SBN009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31147797&oldid=1982218577"